Healthcare • Drug Manufacturers - Specialty & Generic
End-of-day close from stored market data, not a live quote.
Sign in to see your position size
We’ll show you if OPTH is in your portfolio and how much it contributes.
Sign inLoading market dates
No upcoming ex-dividend date announced
No 8-K filings in the last 30 days.
Institutional coverage is still building for this ticker.
Unlock crowding heatmapUnlock filer discoverySentiment: unknown
No recent insider trades detected.
Red flags: 0
10 filers reported a long position in OPTH for Q2 2026. 13-F holdings are filed up to 45 days after the quarter ends.
Q1 2026 shares are adjusted for the 2026-05-20 1-for-30 reverse split.
| Holder | Value | Shares | Shares vs Q1 2026 |
|---|---|---|---|
| Yorkville Advisors Global, LP | $1M | 199K | New |
| AdvisorShares Investments LLC | $523.2K | 102.8K | New |
| TWO SIGMA SECURITIES, LLC | $53.9K | 10.6K | New |
| UBS Group AG | $29.9K | 5.9K | New |
| ROYAL BANK OF CANADA | $10K | 2K | New |
| NATIONAL BANK OF CANADA /FI/ | $3.1K | 598 | New |
| TD Waterhouse Canada Inc. | $1.7K | 333 | New |
| Mariner, LLC | $837 | 122.3K | New |
| NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO | $692 | 136 | New |
| Arax Advisory Partners | $254 | 50 | New |
Unlock detailed insider transactions, institutional holder changes, factor exposures, and personalized alerts. Start free with your own portfolio.